 Elanco Animal Health Inc NYSE: ELAN has reported a Q1 EPS of 0.36, lower than the 0.37 reported a year ago, surpassing analysts view of 0.35. Revenue was 1.225 billion, a decrease of 1 YY, slightly above the consensus of 1.22 billion. 